BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22458493)

  • 21. How can the R.E.N.A.L. nephrometry scoring system aid management of a solid renal mass?
    Wong MH; Cho KY; Ho KL; Wong KW; Lai CT; Man CM; Yiu MK
    Hong Kong Med J; 2014 Feb; 20(1):37-44. PubMed ID: 23878200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
    Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
    J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication.
    Patard JJ; Pantuck AJ; Crepel M; Lam JS; Bellec L; Albouy B; Lopes D; Bernhard JC; Guillé F; Lacroix B; De La Taille A; Salomon L; Pfister C; Soulié M; Tostain J; Ferriere JM; Abbou CC; Colombel M; Belldegrun AS
    Eur Urol; 2007 Jul; 52(1):148-54. PubMed ID: 17240036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
    Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
    J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small renal tumors: correlation of clinical and pathological features with tumor size.
    Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
    J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Marechal JM; Klotz L; Skinner E; Keane T; Claessens I; Sylvester R; ; ; ;
    Eur Urol; 2007 Jun; 51(6):1606-15. PubMed ID: 17140723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy.
    Hew MN; Baseskioglu B; Barwari K; Axwijk PH; Can C; Horenblas S; Bex A; Rosette JJ; Pes MP
    J Urol; 2011 Jul; 186(1):42-6. PubMed ID: 21571340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
    Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nephron-sparing surgery is superior to radical nephrectomy in preserving renal function outcome in tumors larger than 4 cm].
    Boulière F; Crepel M; Bigot P; Pignot G; Bessede T; de la Taille A; Salomon L; Tostain J; Bellec L; Soulié M; Rischmann P; Bernhard JC; Ferrière JM; Pfister C; Albouy B; Colombel M; Zini L; Villers A; Rigaud J; Bouchot O; Patard JJ
    Prog Urol; 2011 Nov; 21(12):842-50. PubMed ID: 22035910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
    Abel EJ; Carrasco A; Culp SH; Matin SF; Tamboli P; Tannir NM; Wood CG
    BJU Int; 2012 Dec; 110(11):1742-6. PubMed ID: 22503066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?].
    Bigot P; Bernhard JC; Crepel M; Bensalah K; Azzouzi AR; de la Taille A; Salomon L; Tostain J; Ficarra V; Pantuck AJ; Belldegrun AS; Méjean A; Ferrière JM; Pfister C; Albouy B; Colombel M; Zini L; Villers A; Montorsi F; Shariat S; Rioux-Leclercq N; Patard JJ
    Prog Urol; 2010 May; 20(5):350-5. PubMed ID: 20471579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. R.E.N.A.L. nephrometry score in clinical stage T1 renal mass: Ramathibodi hospital experience.
    Prasit S; Sirisreetreerux P; Sangkum P; Kijvikai K; Viseshsindh W; Kongchareonsombat W; Leenanupunth C; Kochakarn W
    J Med Assoc Thai; 2015 Feb; 98(2):181-7. PubMed ID: 25842799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery.
    Krambeck A; Iwaszko M; Leibovich B; Cheville J; Frank I; Blute M
    BJU Int; 2008 Jun; 101(11):1375-9. PubMed ID: 18454793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk.
    Rosevear HM; Gellhaus PT; Lightfoot AJ; Kresowik TP; Joudi FN; Tracy CR
    BJU Int; 2012 Mar; 109(5):700-5. PubMed ID: 21777362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm.
    Roos FC; Brenner W; Thomas C; Jäger W; Thüroff JW; Hampel C; Jones J
    Urology; 2012 Mar; 79(3):607-13. PubMed ID: 22386408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.